MMP-9 (N-terminal) Polyclonal antibody proteintech 10375-2-AP

$449.00
In stock
SKU
10375-2-AP

 

MMP9 (N-terminal), MMP9, 67 kDa matrix metalloproteinase-9, 82 kDa matrix metalloproteinase-9, CLG4B

Host / Isotype: Rabbit / IgG Class: Polyclonal
Reactivity: Human And More (7) Immunogen: CatNo: Ag0552 Product name: Recombinant human MMP9 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-100 aa of BC006093 Sequence: MSLWQPLVLVLLVLGCCFAAPRQRQSTLVLFPGDLRTNLTDRQLAEEYLYRYGYTRVAEMRGESKSLGPALLLLQKQLSLPETGELDSATLKAMRTPRCG Predict reactive species
 Applications: WB, IHC, IF/ICC, FC (Intra), CoIP, ELISA Observed Molecular Weight: 707 aa, 78 kDa
Formulation: PBS, Azide, Glycerol GenBank Accession Number: BC006093
Conjugate: Unconjugated Gene Symbol: MMP-9
Tested Applications: Positive WB detected in Gene ID (NCBI): 4318
Application: Western Blot (WB) RRID: AB_10897178
Dilution: WB : 1:500-1:3000 Conjugate: Unconjugated
Tested Reactivity: Human Form: Liquid
Host / Isotype: Rabbit / IgG Background Information: Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, tissue remodeling, and disease processes, such as arthritis or metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. Matrix metalloproteinase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase) (MMP9, synonyms: GELB, CLG4B) degrades collagens type IV and V. Studies in rhesus monkeys suggest that MMP9 is involved in IL-8-induced mobilization hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. The pro-MMP9 is 92 kDa, and it can be detected a processed form of 68 kDa. This protein can exist as a dimer of 180 kDa (PMID:7492685).

 

 

Reviews

Write Your Own Review
You're reviewing:MMP-9 (N-terminal) Polyclonal antibody proteintech 10375-2-AP
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.